heavy%20menstrual%20bleeding
HEAVY MENSTRUAL BLEEDING
Heavy menstrual bleeding is prolonged (>7 days) or excessive (>10 mL) uterine bleeding occurring at regular intervals over several menstrual cycles.
It is menstrual blood loss that is excessive and interferes with patient's physical, emotional, social and quality of life.
It is also referred to as menorrhagia or hypermenorrhea.
It is a common problem in women of reproductive age that usually causes anemia.
Uterine fibroids and polyps are the most common pathology identified.

Introduction

  • Common problem in women of reproductive age (increases with age) which usually causes anemia
    • Most common symptom experienced by women with bleeding disorder

Definition

  • Prolonged (>7 days) or excessive (>80 mL) uterine bleeding occurring at regular intervals over several menstrual cycles
    • Menstrual blood loss that is excessive and interferes with patient’s physical, emotional, social and quality of life

Etiology

  • Causes of abnormal uterine bleeding (AUB) are categorized into the following groups:
    • Discrete structural abnormalities that can be examined with imaging techniques and/or histopathology
      • PALM: polyp, adenomyosis, leiomyoma1, malignancy and hyperplasia
    • Non-structural abnormalities that cannot be defined by imaging or histopathology
      • COEIN: coagulopathy (eg von Willebrand’s disease), ovulatory dysfunction, endometrial, iatrogenic, not yet classified
      • Iatrogenic includes AUB associated with use of hormonal or non-hormonal medications (eg anticoagulation therapy), intrauterine systems or devices, or other local or systemic agents
      •  Not yet classified includes conditions that are rare or ill-defined
    • Other causes include chronic endometrial infection, arteriovenous malformation, hypothyroidism, obesity  
    • 1Please see Leiomyomas Disease Management Chart for details
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
07 Aug 2016
Pravastatin supplementation is associated with improved pregnancy outcomes among women with refractory obstetric antiphospholipid syndrome (APS) who developed preeclampsia (PE) or intrauterine growth restriction (IUGR) during standard antithrombotic therapy, according to a study.
Roshini Claire Anthony, 07 Sep 2016

Estrogen receptor α (ESR1) mutations Y537S and D538G are associated with reduced overall survival (OS) in patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer, according to findings of a secondary analysis of the BOLERO-2* clinical trial.

Christina Leung, Robert Chin, 19 Sep 2017
This review article outlines the prevalence of nausea and vomiting of pregnancy (NVP) and hyperemesis gravidarum (HG), definition of NVP and HG, aetiology, risk factors, complications of HG, recommended investigations, primary care management, hospital and ambulatory daycare, therapeutic management of HG supported by good clinical evidence, discharge planning, and importance of the multidisciplinary team to provide high quality care in patients with NVP and HG.